This article may be expanded with text translated from the corresponding article in Chinese. (March 2020) Click [show] for important translation instructions.
View a machine-translated version of the Chinese article.
Machine translation like DeepL or Google Translate is a useful starting point for translations, but translators must revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
Consider adding a topic to this template: there are already 738 articles in the main category, and specifying|topic= will aid in categorization.
Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing Chinese Wikipedia article at [[:zh:中国疾病预防控制中心]]; see its history for attribution.
You should also add the template {{Translated|zh|中国疾病预防控制中心}} to the talk page.
For more guidance, see Wikipedia:Translation.
Chinese Center for Disease Control and Prevention (CCDC)
Agency overview
Formed
December 23, 1983; 38 years ago (1983-12-23)
Headquarters
155 Changbai Road, Changping District, Beijing, China
The Chinese Center for Disease Control and Prevention (CCDC; simplified Chinese: 中国疾病预防控制中心; traditional Chinese: 中國疾病預防控制中心) is an independent agency of the National Health Commission, based in Changping District, Beijing, China.[1]
Established in 1983, it works to protect public health and safety by providing information to enhance health decisions, and to promote health through partnerships with provincial health departments and other organizations. The CCDC focuses national attention on developing and applying disease prevention and control (especially infectious diseases), environmental health, occupational safety and health, health promotion, prevention and education activities designed to improve the health of the people of the People's Republic of China.[2][3][4]
George F. Gao is the current director general. He has made contributions to the study of inter-species pathogen transmission, and organized the first on 1 November 2018, commemorating the centenary of the Spanish flu. This event was also the 15-year commemoration of the severe acute respiratory syndrome outbreak, which led to China's greater emphasis on public health investment.[5]
The CCDC administers a number of laboratories across China, including the biosafety level 2 facility at the Wuhan Center for Disease Control (sometimes confused with the nearby Wuhan Institute of Virology),[6] which received global media coverage during the COVID-19 pandemic for its research into SARS-like coronaviruses of bat origin.[7][8][9] On January 10, 2020, the CCDC uploaded the genetic sequence of SARS-CoV-2 to GISAID for global dissemination.[10]
The Wuhan office of the CCDC is 300 yards from the wet market that was considered a source of the COVID-19 coronavirus.[11][12]
Workforce[]
As of 2016, the Chinese CDC has 2120 staff with 1876 technical professionals (accounting for 89%), 133 managerial staff (accounting for 6%), and 111 logistic staff (accounting for 5%).
Publications[]
The Chinese CDC publishes or co-sponsors a total of 16 journals,[13] including China CDC Weekly,[14]Journal of Hygiene Research,[15]Chinese Journal of Experimental and Clinical Virology, and Chinese Journal of Epidemiology.
See also[]
List of national public health agencies
Centers for Disease Control and Prevention, US equivalent
Africa Centres for Disease Control and Prevention, Africa equivalent
(国家疾病预防控制局; established on 13 May 2021)
World Health Organization
Wuhan Institute of Virology
References[]
^"Home". Chinese Center for Disease Control and Prevention. Retrieved 6 October 2021. 155 Changbai Road Changping District ,Beijing 102206,China - Chinese address: "地址:北京市昌��区昌百路155号"
^Polack, Fernando (10 December 2020). "Safety and Efficacy of the mRNA Covid-19 Vaccine". New England Journal of Medicine. 383 (27): 2603–2615. doi:10.1056/NEJMoa2034577. PMC7745181. PMID33301246. January 10, 2020, when the SARS-CoV-2 genetic sequence was released by the Chinese Center for Disease Control and Prevention and disseminated globally by the GISAID